May 28, 2020
Cincinnati Children's HLH Research Points to Treatment for COVID-19 Cytokine Storms
May 18, 2020
NellOne Therapeutics files COVID-19 treatment patent
May 05, 2020
Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune(TM)
Apr 22, 2020
Eybna and CannaSoul, Top Cannabis R&D Firms, Join Forces to Prove a Proprietary Terpene Formulation for Treating Viral Infections via Modulation of Cytokine Storm
Apr 01, 2020
Salimetrics' Growing List of Cytokines Which Can Be Reliably Tested in Saliva Now Includes IL-17A, IL-5, and IL-7 for Fast, Easy Salivary Biomarker Analysis
Jan 22, 2020
Okayama University Research: Herbal Medicines Can Treat Stomach Disorders
Jan 09, 2020
Almirall enters into an option agreement to acquire Bioniz Therapeutics and to establish a broad research agreement to further expand its innovative pipeline in medical dermatology
Dec 09, 2019
IsoPlexis Announces "Cracking the IsoCode: Single Cell Functional Biomarkers Challenge"
Nov 11, 2019
Kymera Therapeutics to Present Preclinical Data on its First-in-Class IRAK4 Degraders Demonstrating Robust Inhibition of Inflammatory Responses and Superiority to IRAK4 Kinase Inhibitors
Nov 08, 2019
Latest Developments in the Interleukin-2 (IL-2) Research and Development, 2019 Report
Nov 07, 2019
CalciMedica to Present Results of PD/PK Study in Acute Pancreatitis Patients for its CRAC Channel Inhibitor CM4620 at APA Annual Meeting
Oct 16, 2019
Salimetrics Expands Salivary Cytokine Testing Service for Fast, Easy Salivary Biomarker Analysis
Feb 05, 2019
Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech
Jan 23, 2019
Philogen Announces Collaboration With Celgene
Jan 23, 2019
Philogen Announces Collaboration
Oct 25, 2018
Burst Biologics Has Published a Peer-Reviewed Research Article on Mechanistic Study Using BioBurst Fluid for Spinal Fusion and Foot/Ankle Disorders
Sep 27, 2018
Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
Aug 09, 2018
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs
Jul 17, 2018
Sonnet BioTherapeutics announces successful completion of Immuno-Oncology Discovery Program and Initiation of CMC Development of Platform Assets
Jun 26, 2018
Rigel Initiates Phase 1 Clinical Trial of R835, an IRAK1/4 Inhibitor for Autoimmune and Inflammatory Diseases